Neurofencine(TM) - A New Supplement for Healthier Nerve Functions Affording Better Quality Of Life

Share Article

Gilad&Gilad LLC of Reseda (Los Angeles), California, has re-launched Neurofencine(TM), a first-of-its-kind nutraceutical supplement clinically proven for nerve resilience and pain-free nerve functions. Neurofencine(TM) targets unmet needs of millions of people who cope with circumstances affecting normal nerve functions.

News Image
More than 20 million people in the United States alone cope with circumstances that affect normal nerve functions. Neurofencine(TM), therefore, has wide implications for multitude of people worldwide.

Neurofencine(TM) development is the outcome of breakthrough discoveries made and patented by the neuroscientist founders of Gilad&Gilad. Their findings uncovered the neuroprotective properties of agmatine, a natural metabolite of the amino acid arginine, and were substantiated by extensive worldwide scientific research.

Neurofencine(TM) contains G-agmatine(TM) - Gilad&Gilad's exclusive brand of agmatine, as its principal ingredient. G-agmatine(TM) acts as a shotgun targeting multiple molecular mechanisms critical for healthy nerve functions including: key neurotransmitters; potassium and calcium ion channels; nitric oxide (NO) production; polyamine metabolism; and extracellular proteins.

G-agmatine(TM) is present in small amounts in plant, fish and meat foodstuffs. Recent clinical studies characterized its safety profile and demonstrated that at high amounts dietary G-agmatine(TM) is an effective nutraceutical ingredient for pain-free nerve functions, healthy sensory functions and muscle strength leading to a better quality of life.

The paper describing these clinical trials was published in Pain Medicine (Pain Medicine 11: 356–368, 2010) and selected by the MDLinx editors as one of the most-read articles by US health professionals in the fields of Pain and Neurology for the week of March 17, 2010. These landmark findings were communicated to the American Academy of Neurology meeting in Toronto on April, 2010, and chosen to be presented at the Highlights in the Field of Spine.

According to the authors, "the studies demonstrate that as compared to conventional medications, dietary agmatine (G-agmatine(TM)) is safe and efficacious neuroprotective treatment for alleviating symptoms of neuropathy and improving quality of life in people with sciatica. Moreover, to promote nerve cell survival (i.e., neuroprotection) and proper axonal function (axonoprotection), G-agmatine(TM) may interact with multiple molecular targets which are compromised not only as a result of nerve compression pathologies such as sciatica, but also as a typical consequence of traumatic injuries, metabolic diseases (e.g., diabetic neuropathy), chemotherapy-induced neuropathies, infections (e.g., post herpatic neuralgia (shingles), HIV), fibromyalgia and other neuropathies. And, considering the side effect risks of drugs, this supplement now presents an effective alternative."

Unfortunately, more than 20 million people in the United States alone cope with circumstances that affect normal nerve functions. Neurofencine(TM), therefore, has wide implications for multitude of people worldwide whose need for a dietary supplement affording nerve resilience and pain-free nerve functions remained unmet until now.

Neurofencine(TM) is manufactured in the USA under the highest quality standards and regulations and is available exclusively from Gilad&Gilad. It is presently being sold direct to consumers online, to practicing health professionals and to selective retail health stores. Further information and special launch discounts can be found on the Company's website: For wholesale offers to practicing health professionals and retailers please call (toll free): 1-888-484-4523.

About Gilad&Gilad
Gilad&Gilad LLC is a privately owned USA company in Reseda (Los Angeles), California, with a mission to providing safer and more effective products of superior quality for healthier and resilient nervous system functions for a better quality of life. It was founded in 2000 by Dr. Gad Gilad and Varda Gilad following years of collaborative scientific research and based on their breakthrough discovery of the neuroprotective properties of G-agmatine(TM), Gilad&Gilad's exclusive brand of agmatine. The Company builds its reputation on continuous investment in solid scientific research and sound clinical studies, thus earning the trust of health care professionals and gaining credibility with the public. - For further information about Gilad&Gilad please visit

Gad M. Gilad, Ph.D.
CEO, Gilad&Gilad LLC
Reseda, California
Phone: 1-323-599-0774
Email: gmg(at)GiladandGilad(dot)com

# # #

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Gad Gilad
Visit website